Skip to main content
All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BAMBOO HEALTH · Healthcare and prescription drug monitoring

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Kentucky · House · Senate · $80,000.00 income · posted Jul 21, 2025

Official filing document

 Bills named in this filing 2
  • HR 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
  • S 2121
    SUPPORT for Patients and Communities Reauthorization Act of 2025
 Lobbying activity 1
Health Issues

Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem